Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
3d
HealthDay on MSNFDA Approves Susvimo for Diabetic Macular EdemaThe U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.
Looking for a reliable way to lose weight?? Meet Mounjaro UAE, the latest injectable medication that’s making waves among ...
The findings are reviewed weekly to ensure that the data collection process is reliable. In addition to charts, medication order sheets and medication administration records (MARs) are reviewed daily.
Three teenagers are among 73 individuals who have died from the flu this season, according to San Diego County’s latest ...
Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its 2025 revenue forecast by $1 billion. Watch these crucial price levels.
On the charts, today's pop has NVO on track to snap a three-day losing streak. The stock still hasn't recovered from its ...
President Trump announced tariffs of 25% on both Canada and Mexico, as well as a 10% tariff on China. Click to read.
In the gap between rhetoric and action, plenty of space exists for others, including his own advisers, to impose their own ...
Fleetwood Mac share the drama and turmoil behind every song on Rumours as the classic 1977 album turns 48 on Tuesday, ...
During a routine test, Johnny's middle school nurse discovered his severe scoliosis, a prevalent symptom of Marfan. This unexpectedly set his family on a path to uncover his underlying diagnosis at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results